drugset / Trial / NCT04505189

Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study

NCT04505189

Phase 1/2 Completed 21 enrolled Imperial College London
NaSingle-groupOpen-labelTreatment

Summary

The primary aim of this study is to assess the acceptability and efficacy of treating anorexia nervosa with psilocybin. The secondary aim of this study is to use Magnetic Resonance Imaging (MRI) and Electroencephalography (EEG) to examine the neuronal underpinnings of treatment with psilocybin in this patient group.

Timeline

Start
2021-05-28
Primary completion
2023-12-11
Completion
2024-06-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Psilocybin Other / unclassified 25 mg Oral

Indications